Patient & HCP Communication Strategies

4 Creative Pharma Communication Strategies to Drive Engagement and Trust

The pharmaceutical and life sciences industry is evolving rapidly, but one challenge persists: how to communicate complex science clearly and creatively. In an era of omnichannel communication where patient-centricity is the cornerstone of trust and engagement, pharma companies must go beyond traditional formats to deliver content that resonates with healthcare professionals (HCPs), patients, caregivers, and…...
Read More

Top Stories

Nelson memo

The Nelson Memo: Igniting a Global Open Data

The landscape of scientific research is undergoing a seismic...
Rare diseases

Rare Diseases – An Evolving Medical

A disease is considered rare when it affects fewer than 1 in...

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...

What do Healthcare Professionals Want from Medical Affairs Post COVID-19?

Here's an interesting read for medical affairs teams on how to cater to the digital...
HCP engagement

A 4-Step Plan to Drive HCP Engagement

HCPs are a time-constrained and hard-to-engage audience. Learn how pharma can digitally engage HCPs better...
equity diversity and inclusion

How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications

A roadmap on how to drive advocacy for EDI in medical communications and publications and...
Medical Affairs - 2025

Vision 2025: Decoding the Medical Affairs Landscape

Medical Affairs is a critical strategic pillars of pharma. Read how Medical Affairs will evolve...
Using digital enhancements to maximize engagement

Using Digital Enhancements to Maximize Engagement: How Are Pharma and Publishers Embracing Digital?

Best practices to implement digital enhancements and measure effectiveness...
Building public trust in pharma

3 Factors That Will Help Pharma Build Public Trust

Pharma must engage with patients at all levels to build public trust...

Learn more ABOUT our company.